Assessing the current treatment of atopic dermatitis: Unmet needs - 19/04/17
Doi : 10.1016/j.jaci.2017.01.010
Donald Y.M. Leung, MD, PhD a, ⁎ 
, Emma Guttman-Yassky, MD, PhD b
, Emma Guttman-Yassky, MD, PhD b a Department of Pediatrics, National Jewish Health, Denver, Colo
b Department of Dermatology and the Laboratory for Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY
∗Corresponding author: Donald Y. M. Leung, MD, PhD, National Jewish Health, 1400 Jackson St, Rm K926i, Denver, CO 80206.National Jewish Health1400 Jackson StRm K926iDenverCO80206
Key words : Atopic dermatitis, eczema, immune, therapy
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: D. Y. M. Leung receives grant support form MedImmune; serves as a consultant for Novartis, Regeneron, and Sanofi-Aventis; and receives payments for reviewing from Omnia-Prova Education Collaborative. E. Guttman-Yassky serves on the board for Sanofi-Aventis, Regeneron, Stiefel/GlaxoSmithKline, MedImmune, Celgene, Anacor, Leo Pharma, AnaptysBio, Celsus, Dermira, Galderma, Novartis, Pfizer, Vitae, Glenmark, AbbVie, and Asana Biosciences; serves as a consultant for Regeneron, Sanofi-Aventis, MedImmune, Celgene, Stiefel/GlaxoSmithKline, Celsus, BMS, Amgen, Drais, AbbVie, Anacor, AnaptysBio, Dermira, Galderma, Leo Pharma, Novartis, Pfizer, Vitae Mitsubishi Tanabe, Eli Lilly, Glenmark, and Asana Biosciences; and receives grant support from Regeneron, Celgene, BMS, Janssen, Dermira, Leo Pharma, Merck, Novartis, and UCB. |
© 2017
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 139 - N° 4S
P. S47-S48 - avril 2017 Retour au numéro
Article précédent
- The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies
- Patrick M. Brunner, Emma Guttman-Yassky, Donald Y.M. Leung
- The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?